Female Reproductive Cancer Clinical Trial
Official title:
Early Oral Feeding After a Gynaecologic Oncologic Laparotomy: A Randomized Controlled Trial
RATIONALE: Abdominal pain and nausea and vomiting may be lessened by waiting after surgery
before eating foods by mouth. It is not yet known which feeding schedule is more effective
in patients undergoing surgery.
PURPOSE: This randomized clinical trial is comparing two feeding schedules after laparotomy
in patients with gynecologic cancer.
OBJECTIVES:
Primary
- To investigate the relationship between the different policies of realimentation (early
oral feedings versus traditional feedings) and the length of hospital stay following a
laparotomy in patients with gynecologic oncologic disease.
- To assess the degree of postoperative abdominal pain in these patients.
- To evaluate the incidence of ileus symptoms, including nausea and vomiting, and the
postoperative recovery of intestinal activity in these patients.
- To determine the incidence of postoperative complications in these patients.
- To elucidate the global postoperative patient's satisfaction and the quality of life in
both groups of patients.
OUTLINE: Patients are stratified according to laparotomy with or without intestinal
resection (yes vs no), and presence of ovarian cancer (yes vs no). Patients are randomized
to 1 of 2 groups at the end of surgery.
- Group 1 (early feeding): Patients are offered a liquid diet on day 1 for 24 hours
following surgery. Beginning on day 2, patients who tolerate a liquid diet are offered
a regular diet until hospital discharge.
- Group 2 (traditional feeding): Patients are offered nothing by mouth on days 1 and 2
following surgery. Beginning on day 3, patients are offered a liquid diet for 24 hours.
Beginning on day 4, patients who tolerate a liquid diet (i.e., no nausea and vomiting)
are offered a semi-solid diet for 24 hours. Beginning on day 5, patients who tolerate a
semi-solid diet are offered a light regular diet until hospital discharge.
Data is collected through the Post-Operative Pain Questionnaire, Bowel Function Table,
Global Postoperative Patient's Satisfaction Questionnaire, Postoperative Complication and
Hospital Stay Questionnaire, and the Quality of Life Questionnaires EORTC OV-28 and EORTC
QLQ-C30.
;
Allocation: Randomized, Primary Purpose: Supportive Care
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02096783 -
Scripted Sexual Health Informational Intervention in Improving Sexual Function in Patients With Gynecologic Cancer
|
N/A | |
Completed |
NCT00390234 -
Ziv-aflibercept in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gynecologic Soft Tissue Sarcoma
|
Phase 2 | |
Active, not recruiting |
NCT01867606 -
Serum Bovine Immunoglobulin Protein Isolate in Improving Quality of Life and Post-Operative Recovery in Patients With Gynecological Cancer After Undergoing Surgery
|
Phase 2 | |
Completed |
NCT00182767 -
Ixabepilone and Liposomal Doxorubicin in Advanced Ovarian Cancer
|
Phase 1/Phase 2 | |
Completed |
NCT01901835 -
Media Diversion in Improving Quality of Life in Patients With Recurrent Gynecologic Cancers Receiving Chemotherapy
|
N/A |